Renzenbrink & Partner advised the opseo Group, a portfolio company of Apheon, on the acquisition of the intensive care provider Lebenswert from French healthcare group Clariane.<\/p>\n\n
Based in Baden-Wuerttemberg and Bavaria, Lebenswert has specialized in outpatient intensive care for over 15 years. The company operates six intensive care communities and an outpatient nursing service. With its comprehensive care offering for patients with complex medical needs, Lebenswert is a well-established provider in Southern Germany. <\/p>\n\n
With this acquisition, opseo \u2013 one of the largest providers of outpatient intensive care for adults and children in Germany \u2013 strengthens its regional footprint in Southern Germany and continues its strategic expansion in the field of specialized outpatient intensive care.<\/p>\n\n
The Renzenbrink & Partner team consisted of Dr. Dennis Schlottmann<\/a> (Corporate \/ M&A) and Dr. Alexander Haunschild<\/a> (Corporate \/ M&A).<\/p>\n\n <\/p>\n","protected":false},"featured_media":1936,"template":"","class_list":["post-1935","deals","type-deals","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n